Personalized Reimbursement Model (PRM) program: A real-world data platform of cancer drugs use to improve and personalize drug pricing and reimbursement in France

por Squara, Pierre-Alexandre, Luu, Vinh-Phuc, Pérol, David, Coudert, Bruno, Machuron, Valérie, Bachot, Camille, Samelson, Laurence, Florentin, Virginie, Pinguet, Jean-Marc, Ben Hadj Yahia, Béchir
Publicado 2022

Incidence and survival of transthyretin amyloid cardiomyopathy from a French nationwide study of in- and out-patient databases

por Damy, Thibaud, Bourel, Guillaume, Slama, Michel, Algalarrondo, Vincent, Lairez, Olivier, Fournier, Pauline, Costa, Jérôme, Pelcot, Françoise, Farrugia, Agnès, Zaleski, Isabelle Durand, Lilliu, Hervé, Rault, Caroline, Bartoli, Mathilde, Fievez, Stéphane, Granghaud, Anna, Rudant, Jeremie, Coste, Agathe, Cosson, Charlotte Noirot, Squara, Pierre-Alexandre, Narbeburu, Marion, De Neuville, Bertrand, Charron, Philippe
Publicado 2023